Los estudios han validado su eficacia, no solo en la reduccin del peso corporal, sino tambin en la mejora de varios parmetros metablicos, lo que los hace particularmente valiosos para pacientes con obesidad y comorbilidades como la diabetes tipo 2, el sndrome metablico y la incapacidad por el control diettico en pautas hipocalricas
These characteristics included greater reduction of hemoglobin A1c with treatment, longer duration of diabetes diagnosis and older subject age
The risk can be lowered by reducing the dose of sulfonylurea like gliclazide or insulin, when initiating treatment with GLP-1 analogue
10.2174/13816128113199990421 62 SeiwerthS.MilavicM.VukojevicJ.GojkovicS.KrezicI.VuleticL
A review of epidermal maturation arrest: a unique entity or another description of persistent granulation tissue
The short answer is that the medication is designed for flexibility, but the best time often depends on your personal schedule and how your body responds to the treatment